WG
WGS icon

Winton Group’s GeneDx Holdings WGS Stock Holding History

Winton Group’s Portfolio WGS Stock Details WGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-7,200
Closed -$462K – 1532
2026
Q1 		$462K Buy
+7,200
New +$657K 0.02% 734
2023
Q4 		– Sell
-20,145
Closed -$73.3K – 865
2023
Q3 		$73.3K Buy
20,145
+6,985
+53% +$38.3K 0.01% 737
2023
Q2 		$78.4K Buy
+13,160
New +$104K 0.01% 726

Other funds holding WGS

CM
Corvex Management New York $3.27B AUM 38.53% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Winton Group's WGS Position: Q2 2026 in Review

Winton Group sold out of GeneDx Holdings (WGS) in Q2 2026, closing a stake of 7,200 shares — an estimated $462K sold.

Winton Group first reported a position in WGS in Q2 2023 and held it in 3 quarters. The position peaked at $462K in Q1 2026. 223 funds tracked by Wall St. Rank hold WGS as of Q2 2026.

  • Winton Group reported no remaining GeneDx Holdings position as of Q2 2026 after selling out during the quarter.
  • Winton Group sold 7,200 GeneDx Holdings shares in Q2 2026, an estimated $462K.
  • Winton Group first reported a position in GeneDx Holdings in Q2 2023 and held it in 3 quarters.
  • Winton Group's GeneDx Holdings position peaked at $462K in Q1 2026.
  • 223 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2026.

Based on Winton Group's 13F filing for Q2 2026, filed 7 Aug 2026.